Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy
- 27 June 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 49 (8), 1711-1721
- https://doi.org/10.1007/s00125-006-0316-2
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Biologic actions and therapeutic potential of the proglucagon-derived peptidesNature Clinical Practice Endocrinology & Metabolism, 2005
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialThe Lancet, 2005
- Basic Approach to Managing Hyperglycemia for the NonendocrinologistThe American Journal of Cardiology, 2005
- ADVANCE—Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baselineDiabetic Medicine, 2005
- Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 DiabetesDiabetes Care, 2004
- Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamideDiabetes/Metabolism Research and Reviews, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Insulin Use in NIDDMDiabetes Care, 1990